IP Library Granted Patent US 8,440,792
Granted Patent B2
US 8,440,792 · App. 12/911,693 · Granted May 14, 2013

Antimicrobial peptides and derived metapeptides

Inventors: Michael R. Yeaman (Redondo Beach, CA); Alexander J. Shen (Torrance, CA)
Assignee: Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,440,792
App. No.
12/911,693
Granted
May 14, 2013
Kind
B2
Abstract

The peptides and derivative metapeptides based upon natural antimicrobial peptides have potent and broad spectrum activity against pathogens exhibiting multiple antibiotic resistance. Specific peptides can also potentiate the antimicrobial functions of leukocytes, such as neutrophils. In addition, they exhibit lower inherent mammalian cell toxicities than conventional antimicrobial peptides, and overcome problems of toxicity, immunogenicity, and shortness of duration of effectiveness due to biodegradation, retaining activity in plasma and serum. The peptides and derivative metapeptides exhibit rapid microbicidal activities in vitro, can be used to potentiate conventional antimicrobial agents, to potentiate other antimicrobial peptides and are active against many organisms that exhibit resistance to multiple antibiotics currently in existence.

Claims (30)

1. An isolated antimicrobial peptide comprising:

a peptide of from 13 to 18 amino acids containing a 12 amino acid core sequence: aa 1 -aa 2 -aa 3 -aa 4 -aa 5 -aa 6 -aa 7 -aa 8 -aa 9 -aa 10 -aa 11 -aa 12 , wherein aa 1 is the amino- terminus of the peptide and is selected from the group consisting of leucine, isoleucine, alanine, valine, serine, lysine and glycine; aa 2 is selected from the group consisting of leucine, isoleucine, alanine, valine, serine and arginine; aa 3 is selected from the group consisting of phenylalanine, tryptophan and tyrosine; aa 4 and aa 5 are selected from the group consisting of lysine, arginine and histidine; one of aa 6 and aa 7 is selected from the group consisting of phenylalanine, tryptophan and tyrosine, such that when aa 6 is phenylalanine aa 7 is selected from the group consisting of lysine, arginine and histidine, when aa 6 is tryptophan aa 7 is lysine, and when aa 7 is phenylalanine aa 6 is leucine; aa 8 is selected from the group consisting of lysine, arginine, histidine and asparagine; aa 9 is selected from the group consisting of lysine, arginine and histidine; aa 10 is selected from the group consisting of leucine, isoleucine, alanine, valine and serine; aa 11 is selected from the group consisting of leucine, isoleucine, alanine, valine, serine and lysine; and aa 12 is selected from the group consisting of lysine, arginine and histidine; and retromers, extensions, combinations, and fusions thereof, wherein said peptide has antimicrobial activity.

2. The antimicrobial peptide of claim 1 , wherein aa 1 is selected from the group consisting of alanine, lysine and glycine; aa 2 is selected from the group consisting of leucine and arginine; aa 3 is tyrosine; aa 4 and aa 5 are selected from the group consisting of lysine and arginine; aa 8 is selected from the group consisting of lysine and asparagine; aa 9 is lysine; aa 10 is selected from the group consisting of leucine and isoleucine; aa 11 is selected from the group consisting of leucine and lysine; and aa 12 is selected from the group consisting of lysine and arginine.

3. The antimicrobial peptide of claim 1 , wherein one of aa 6 and aa 7 is selected from the group consisting of phenylalanine and tryptophan, such that when aa 6 is phenylalanine aa 7 is selected from the group consisting of lysine and arginine, when aa 6 is tryptophan aa 7 is lysine, and when aa 7 is phenylalanine aa 6 is leucine.

4. The antimicrobial peptide of claim 1 , wherein aa 1 is selected from the group consisting of alanine, lysine and glycine; aa 2 is selected from the group consisting of leucine and arginine; aa 3 is tyrosine; aa 6 is selected from the group consisting of phenylalanine, tryptophan and tyrosine; aa 7 is selected from the group consisting of lysine and arginine; aa 8 is selected from the group consisting of lysine and asparagine; aa 9 is lysine; aa 10 is selected from the group consisting of leucine and isoleucine; aa 11 is selected from the group consisting of leucine and lysine; and aa 12 is selected from the group consisting of lysine and arginine.

5. The antimicrobial peptide of claim 4 , wherein when aa 6 is phenylalanine aa 7 is lysine or arginine, and when aa 6 is tryptophan aa 7 is lysine.

6. The antimicrobial peptide of claim 1 , wherein aa 6 is selected from the group consisting of phenylalanine, tryptophan and tyrosine; and aa 7 is selected from the group consisting of lysine and arginine.

7. The antimicrobial peptide of claim 6 , wherein when aa 6 is phenylalanine aa 7 is selected from the group consisting of lysine and arginine, and when aa 6 is tryptophan aa 7 is lysine.

8. The antimicrobial peptide of claim 1 , wherein aa 1 is serine.

9. The antimicrobial peptide of claim 8 , wherein aa 2 is selected from the group consisting of leucine and arginine; aa 3 is tyrosine; aa 4 and aa 5 are selected from the group consisting of lysine and arginine; aa 8 is selected from the group consisting of lysine and asparagine; aa 9 is lysine; aa 10 is selected from the group consisting of leucine and isoleucine; aa 11 is selected from the group consisting of leucine and lysine; and aa 12 is selected from the group consisting of lysine and arginine.

10. The antimicrobial peptide of claim 8 , wherein one of aa 6 and aa 7 is selected from the group consisting of phenylalanine and tryptophan, such that when aa 6 is phenylalanine aa 7 is selected from the group consisting of lysine and arginine, when aa 6 is tryptophan aa 7 is lysine, and when aa 7 is phenylalanine aa 6 is leucine.

11. The antimicrobial peptide of claim 8 , aa 2 is selected from the group consisting of leucine and arginine; aa 3 is tyrosine; aa 6 is selected from the group consisting of phenylalanine, tryptophan and tyrosine; aa 7 is selected from the group consisting of lysine and arginine; aa 8 is selected from the group consisting of lysine and asparagine; aa 9 is lysine; aa 10 is selected from the group consisting of leucine and isoleucine; aa 11 is selected from the group consisting of leucine and lysine; and aa 12 is selected from the group consisting of lysine and arginine.

12. The antimicrobial peptide of claim 11 , wherein when aa 6 is phenylalanine aa 7 is lysine or arginine, and when aa 6 is tryptophan aa 7 is lysine.

13. The antimicrobial peptide of claim 8 , wherein aa 6 is selected from the group consisting of phenylalanine, tryptophan and tyrosine; and aa 7 is selected from the group consisting of lysine and arginine.

14. The antimicrobial peptide of claim 13 , wherein when aa 6 is phenylalanine aa 7 is selected from the group consisting of lysine and arginine, and when aa 6 is tryptophan aa 7 is lysine.

15. The antimicrobial peptide of claim 8 , wherein aa 6 is leucine and aa 7 is phenylalanine.

16. The antimicrobial peptide of claim 1 , wherein aa 1 is serine; aa 2 is leucine; aa 3 is tyrosine; aa 4 is lysine; aa 5 is arginine; aa 6 is leucine; aa 7 is phenylalanine; aa 8 is lysine; aa 9 is lysine; aa 10 is leucine; aa 11 is lysine; and aa 12 is lysine.

17. An isolated antimicrobial peptide comprising:

a peptide of from 13 to 18 amino acids containing a 13 amino acid core sequence: aa 1 -aa 2 -aa 3 -aa 4 -aa 5 -aa 6 -aa 7 -aa 8 -aa 9 -aa 10 -aa 11 -aa 12 -aa 13 , wherein aa 1 is the amino-terminus of the peptide and is selected from the group consisting of leucine, isoleucine, alanine, valine, serine, lysine and glycine; aa 2 is selected from the group consisting of leucine, isoleucine, alanine, valine, serine and arginine; aa 3 is selected from the group consisting of phenylalanine, tryptophan, tyrosine; aa 4 and aa 5 are selected from the group consisting of lysine, arginine and histidine; one of aa 6 and aa 7 is selected from the group consisting of phenylalanine, tryptophan, tyrosine, and the other of aa 6 , and aa 7 is selected from the group consisting of lysine, arginine and leucine, wherein when aa 6 is phenylalanine aa 7 is selected from the group consisting of lysine and arginine, when aa 6 is tryptophan aa 7 is lysine, and when aa 7 is phenylalanine aa 6 is leucine; aa 8 is selected from the group consisting of lysine, arginine, histidine and asparagine; aa 9 is selected from the group consisting of lysine, arginine and histidine; aa 10 is selected from the group consisting of leucine, isoleucine, alanine, valine and serine; aa 11 is selected from the group consisting of leucine, isoleucine, alanine, valine, serine and lysine; aa 12 is selected from the group consisting of lysine, arginine and histidine; and aa 13 is selected from the group consisting of leucine, isoleucine; alanine, valine, serine, arginine and phenylalanine; and retromers, extensions, combinations, and fusions thereof, wherein said peptide has antimicrobial activity.

18. The antimicrobial peptide of claim 17 , wherein aa 1 is selected from the group consisting of alanine, lysine and glycine; aa 2 is selected from the group consisting of leucine and arginine; aa 3 is tyrosine; aa 4 and aa 5 are selected from the group consisting of lysine, arginine and histidine; aa 8 is selected from the group consisting of lysine and asparagine; aa 9 is lysine; aa 10 is selected from the group consisting of leucine and isoleucine; aa 11 is selected from the group consisting of leucine and lysine; and aa 12 is selected from the group consisting of lysine and arginine.

19. The antimicrobial peptide of claim 18 , wherein aa 13 is selected from the group consisting of serine, leucine, arginine and phenylalanine.

20. The antimicrobial peptide of claim 17 , wherein aa 1 is serine; aa 2 is leucine; aa 3 is tyrosine; aa 4 is lysine; aa 5 is arginine; aa 6 is leucine; aa 7 is phenylalanine; aa 8 is lysine; aa 9 is lysine; aa 10 is leucine; aa11 is lysine; aa 12 is lysine and aa 13 is phenylalanine.

21. An isolated antimicrobial peptide comprising:

a peptide of from 13 to 18 amino acids containing a 12 amino acid core sequence: aa 1 -aa 2 -aa 3 -aa 4 -aa 5 -aa 6 -aa 7 -aa 8 -aa 9 -aa 10 -aa 11 -aa 12 , wherein aa 1 is the amino-terminus of the peptide and is selected from the group consisting of leucine, isoleucine, alanine, valine, serine, lysine and glycine; aa 2 is selected from the group consisting of leucine, isoleucine, alanine, valine, serine and arginine; aa 3 is selected from the group consisting of phenylalanine, tryptophan and tyrosine; aa 4 and aa 5 are selected from the group consisting of lysine, arginine and histidine; one of aa 6 and aa 7 is selected from the group consisting of phenylalanine, tryptophan and tyrosine, such that when aa 6 is phenylalanine aa 7 is selected from the group consisting of lysine, arginine and histidine, when aa 6 is tryptophan aa 7 is lysine, and when aa 7 is phenylalanine aa 6 is leucine; aa 8 is selected from the group consisting of lysine, arginine, histidine and asparagine; aa 9 is selected from the group consisting of lysine, arginine and histidine; aa 10 is selected from the group consisting of leucine, isoleucine, alanine, valine and serine; aa 11 is selected from the group consisting of leucine, isoleucine, alanine, valine, serine and lysine; and aa 12 is selected from the group consisting of lysine, arginine and histidine; and retromers, extensions, combinations, and fusions thereof, wherein said peptide has antimicrobial activity and wherein said peptide comprises a modified amino acid at any one of the amino acid residues of said peptide, wherein said modified amino acid is selected from the group consisting of D-isomeric amino acid, N-epsilon-monomethyl-lysine, beta branched amino acid, N-methyl amino acid, alpha, beta-dehydro amino acid, and fluorinated amino acid.

22. The antimicrobial peptide of claim 21 , wherein said peptide comprises a beta branched amino acid.

23. The antimicrobial peptide of claim 21 , wherein said peptide comprises a beta-dehydro amino acid.

24. An isolated antimicrobial peptide comprising:

a peptide of from 13 to 18 amino acids containing a 13 amino acid core sequence: aa 1 -aa 2 -aa 3 -aa 4 -aa 5 -aa 6 -aa 7 -aa 8 -aa 9 -aa 10 -aa 11 -aa 12 -aa 13 , wherein aa 1 is the amino-terminus of the peptide and is selected from the group consisting of leucine, isoleucine, alanine, valine, serine, lysine and glycine; aa 2 is selected from the group consisting of leucine, isoleucine, alanine, valine, serine and arginine; aa 3 is selected from the group consisting of phenylalanine, tryptophan, tyrosine; aa 4 and aa 5 are selected from the group consisting of lysine, arginine and histidine; one of aa 6 and aa 7 is selected from the group consisting of phenylalanine, tryptophan, tyrosine, and the other of aa 6 and aa 7 is selected from the group consisting of lysine, arginine and leucine, wherein when aa 6 is phenylalanine aa 7 is selected from the group consisting of lysine and arginine, when aa 6 is tryptophan aa 7 is lysine, and when aa 7 is phenylalanine aa 6 is leucine; aa 8 is selected from the group consisting of lysine, arginine, histidine and asparagine; aa 9 is selected from the group consisting of lysine, arginine and histidine; aa 10 is selected from the group consisting of leucine, isoleucine, alanine, valine and serine; aa 11 is selected from the group consisting of leucine, isoleucine, alanine, valine, serine and lysine; aa 12 is selected from the group consisting of lysine, arginine and histidine; and aa 13 is selected from the group consisting of leucine, isoleucine; alanine, valine, serine, arginine and phenylalanine; and retromers, extensions, combinations, and fusions thereof, wherein said peptide has antimicrobial activity and wherein said peptide comprises a modified amino acid at any one of the amino acid residues of said peptide, wherein said modified amino acid is selected from the group consisting of D-isomeric amino acid, N-epsilon-monomethyl-lysine, beta branched amino acid, N-methyl amino acid, alpha, beta-dehydro amino acid, and fluorinated amino acid.

25. The antimicrobial peptide of claim 24 , wherein said peptide comprises a beta branched amino acid.

26. The antimicrobial peptide of claim 24 , wherein said peptide comprises a beta-dehydro amino acid.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 12, 2019
From: YEAMAN, MICHAEL R.; SHEN, ALEXANDER J.
To: HARBOR -UCLA RESEARCH AND EDUCATION INSTITUTE
Reel/Frame 048873/0220 →
CHANGE OF NAME Recorded Apr 12, 2019
From: HARBOR -UCLA RESEARCH AND EDUCATION INSTITUTE
To: LOS ANGELES BIOMEDICAL RESEARCH INSTITUTE AT HARBOR-UCLA MEDICAL CENTER
Reel/Frame 048873/0322 →
Continuity (4)
Continuation 09648816 · Aug 25, 2000
Continuation In Part 09622561
Continuation 09025319 · Feb 18, 1998
Related Publication 20110190474A1 · Aug 4, 2011